Affordable Access

Association between FDA black box warnings and Medicare formulary coverage changes.

Authors
  • Dhruva, Sanket S1
  • Karaca-Mandic, Pinar
  • Shah, Nilay D
  • Shaw, Daniel L
  • Ross, Joseph S
  • 1 Yale School of Medicine, 333 Cedar St, SHM I-456, Box 208088, New Haven, CT 06520-8088. E-mail: [email protected]
Type
Published Article
Journal
The American journal of managed care
Publication Date
Sep 01, 2017
Volume
23
Issue
9
Identifiers
PMID: 29087169
Source
Medline
License
Unknown

Abstract

Medicare formularies became more restrictive for half of the drugs that recently received new FDA black box warnings for death and/or cardiovascular risk and for which safer drug alternatives are available. However, a substantial proportion of formularies remained unrestrictive, suggesting inconsistent responses to new safety information to curtail the use of these medications.

Report this publication

Statistics

Seen <100 times